🔗 Share this article

A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Experimental Drug Acquiring Traction Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Followers are encouraged to contact these accounts privately for source information, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a robust trade exists on messaging services, where groups with numerous of participants share comparison photos, administration instructions and claims of rapid UK delivery. Sellers promote the substance there before redirecting customers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Professionals Express Concerns

However, physicians and pharmacists have cautions that the sale of what is still an unapproved drug in the United Kingdom is worrisome and could result in individuals administering substances of unknown origin.

Some professionals stated the popularity for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the British medical regulations.

Several content creators attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach medicines, marketing, and consumer regulations, risking penalties, prosecution or imprisonment.

Platform Response and Content Removal

Based on the social media company, the service has removed violative content and prohibited related hashtags and search suggestions. The organization stated it was committed to maintaining the platform safe and allocating resources in strengthening enforcement strategies.

Online Trading Operations

Investigations also discovered communities with up to nine thousand members selling retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up groups with thousands of users, populated with photos of slimming results, glowing reviews and detailed guides for mixing or administering at residence.

After minutes of joining one community, a vendor posted WhatsApp details, where most transactions occur. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None inquired about body mass, medical conditions or past usage.

Item Information and Costs

Within these communities, messages show dark colored parcels with postal service stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use injectors typically priced at £160 for 20 milligrams. When questioned how long a pen should be used, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Service Oversight and Security Measures

A representative for the messaging service stated it actively monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering materials they can’t verify. Although the science behind this drug is valid, these digital versions may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current price rises for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are using social media. But counterfeit injections are highly risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.

Her staff has already encountered individuals harmed by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”

Producer Statement

A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly investigational substance not yet approved … may subject users to possibly serious health risks”.